KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Amgen's Profit After Tax rose 11259.97% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.7 billion, marking a year-over-year increase of 8853.3%. This contributed to the annual value of $7.7 billion for FY2025, which is 8853.3% up from last year.
  • According to the latest figures from Q4 2025, Amgen's Profit After Tax is $1.3 billion, which was up 11259.97% from $3.2 billion recorded in Q3 2025.
  • Amgen's 5-year Profit After Tax high stood at $3.2 billion for Q3 2025, and its period low was -$113.0 million during Q1 2024.
  • Moreover, its 5-year median value for Profit After Tax was $1.5 billion (2022), whereas its average is $1.5 billion.
  • In the last 5 years, Amgen's Profit After Tax crashed by 10397.75% in 2024 and then skyrocketed by 163097.35% in 2025.
  • Amgen's Profit After Tax (Quarter) stood at $1.9 billion in 2021, then fell by 14.9% to $1.6 billion in 2022, then tumbled by 52.54% to $767.0 million in 2023, then dropped by 18.25% to $627.0 million in 2024, then skyrocketed by 112.6% to $1.3 billion in 2025.
  • Its Profit After Tax was $1.3 billion in Q4 2025, compared to $3.2 billion in Q3 2025 and $1.4 billion in Q2 2025.